Efficacy and safety of mevrometostat (M) in combination with enzalutamide (E) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Data from a phase 1 study. Results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results